News Conference News ACC 2022 PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI Todd Neale April 03, 2022
News Conference News EuroPCR 2021 Transradial PCI Bests Femoral Access in Complex Cases: COLOR Michael O'Riordan May 21, 2021
News Daily News FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries Shelley Wood February 16, 2021
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News AHA 2019 EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl Todd Neale November 18, 2019
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Daily News Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes Todd Neale April 11, 2019
News Daily News Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show Michael O'Riordan October 17, 2018
News Conference News TCT 2018 Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques Yael L. Maxwell September 24, 2018
News Daily News Serial CTA Shines a Light on Statin Effects in Subclinical CAD Yael L. Maxwell June 15, 2018
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
News Industry News Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque November 01, 2016
News Daily News Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA Caitlin E. Cox October 18, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Industry News Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) September 20, 2016
News Daily News Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas Todd Neale September 19, 2016